600276 恒瑞医药
2024/03 - 三个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额1,254,5997,643,6651,265,2654,218,8163,431,935
投资活动产生之现金流量净额(750,390)1,222,315390,289(546,263)1,797,829
筹资活动产生之现金流量净额(18,135)(3,144,426)(318,770)(998,322)291,188
汇率变动对现金及现金等价物的影响(18,208)12,53380,497(16,866)(89,079)
现金及现金等价物净增加/(减少)467,8665,734,0871,417,2812,657,3655,431,873
期初现金及现金等价物余额20,271,52414,537,43713,120,15610,462,7915,030,918
期末现金及现金等价物余额20,739,39020,271,52414,537,43713,120,15610,462,791